Overall, our results suggest that, in addition to its direct cytotoxic effects on tumor cells, RA190 is able to counteract the immunosuppressive effects of MDSCs, induce a more immunogenic phenotype, and elicit effective CD8+ T cell mediated antitumor immunity. Here, CD8A is linked to neoplasm.